PDSB: PDS Biotechnology Corporation Stock

by  •  • Comments Off on PDSB: PDS Biotechnology Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 47.93
Enterprise Value ($M) 27.23
Book Value ($M) 19.00
Book Value / Share 0.42
Price / Book 2.48
NCAV ($M) 18.70
NCAV / Share 0.41
Price / NCAV 2.52

Profitability (mra)
Return on Invested Capital (ROIC) -0.92
Return on Assets (ROA) -0.55
Return on Equity (ROE) -1.01

Liquidity (mrq)
Quick Ratio 2.64
Current Ratio 2.64

Balance Sheet (mrq) ($M)
Current Assets 45.05
Assets 45.36
Liabilities 26.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -36.32
Net Income -37.61
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -35.03
Cash from Investing -0.03
Cash from Financing 20.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-08 13G/A BlackRock, Inc. 4.96 -3.18

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 27,972 108,242 25.84
2025-04-16 52,268 134,931 38.74
2025-04-15 90,895 216,767 41.93

(click for more detail)

Similar Companies
PALI – Palisade Bio, Inc. PASG – Passage Bio, Inc.
PCSA – Processa Pharmaceuticals, Inc. PHIO – Phio Pharmaceuticals Corp.
PLUR – Pluri Inc.


Financial data and stock pages provided by
Fintel.io